Changes in proinflammatory cytokines and white matter in chronically stressed rats

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 597-607

  Yang, Ping ^a   Gao, Zhenyong ^a   Zhang, Handi ^a   Fang, Zeman ^a   Wu, Cairu ^a   Xu, Haiyun ^a   Huang, Qing Jun ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Cytokines; Depression; Myelination; Oligodendrocytes; Stress

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELIN BASIC PROTEIN; SUCROSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHRONIC STRESS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DIETARY INTAKE; FORCED SWIM TEST; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; IMMOBILITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOLECULAR IMAGING; NONHUMAN; OLIGODENDROGLIA; OPEN FIELD BEHAVIOR; PREFRONTAL CORTEX; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; WHITE MATTER;

EID: 84929157959     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S78131     Document Type: Article

References (50)

1. Wetzler S, Kahn R, Strauman TJ, Dubro A. Diagnosis of major depression by self-report. J Pers Assess. 1989;53:22–30.
2. Schechter LE. Major depressive disorder. Curr Pharm Des. 2005;11:143–144.
3. Dantzer R, Wollman E, Vitkovic L, Yirmiya R. Cytokines and depression: fortuitous or causative association. Mol Psychiatry. 1999;4:328–332.
4. Serafini G, Pompili M, Elena Seretti M, et al. The role of inflammatory cytokines in suicidal behavior: a systematic review. Eur Neuropsychopharmacol. 2013;23:1672–1686.
5. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732–741.
6. Miller AH. Depression and immunity: a role for T cells? Brain Behav. Immun. 2010;24:1–8.
7. Piser TM. Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants. Brain Behav Immun. 2010;4:515–524.
8. Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo controlled randomised phase III trial. Lancet. 2006;367:29–35.
9. Colin A, Reggers J, Castronovo V, Ansseau M. [Lipids, depression and suicide]. Encephale. 2003;29:49–58. French.
10. Li L, Ma N, Li Z, et al. Prefrontal white matter abnormalities in young adult with major depressive disorder: a diffusion tensor imaging study. Brain Res. 2007;1168:124–128.
11. Ma N, Li L, Shu N, et al. White matter abnormalities in first-episode, treatment-naive young adults with major depressive disorder. Am J Psychiatry. 2007;164:823–826.
12. Tham MW, Woon PS, Sum MY, Lee TS, Sim K. White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies. J Affect Disord. 2011;132:26–36.
13. Zou K, Huang X, Li T, et al. Alterations of white matter integrity in adults with major depressive disorder: a magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33:525–530.
14. Kiesepp T, Eerola M, Mäntylä R, et al. Major depressive disorder and white matter abnormalities: a diffusion tensor imaging study with tract-based spatial statistics. J Affect Disord. 2010;120:240–244.
15. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67:269–275.
16. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry. 2005;10:309–322.
17. Savignac HM, Hyland NP, Dinan TG, Cryan JF. The effects of repeated social interaction stress on behavioural and physiological parameters in a stress-sensitive mouse strain. Behav Brain Res. 2011;216:576–584.
18. Fu X, Zunich SM, O’Connor JC, Kavelaars A, Dantzer R, Kelley KW. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2, 3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation. 2010;7:43.
19. Rizzo A, Bevilacqua N, Guida L, et al. Effect of resveratrol and modulation of cytokine production on human periodontal ligament cells. Cytokine. 2012;60:197–204.
20. Banasr M, Valentine GW, Li XY, Gourley SL, Taylor JR, Duman RS. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry. 2007;62:496–504.
21. Czeh B, Muller-Keuker JI, Rygula R, et al. Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology. 2007;32:1490–1503.
22. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia. 2000;31:219–231.
23. Wennström M, Hellsten J, Ekstrand J, Lindgren H, Tingström A. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol Psychiatry. 2006;59:178–186.
24. Farooq RK, Isingrini E, Tanti A, et al. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? Behav Brain Res. 2012;231:130–137.
25. Liu W, Sheng H, Xu Y, et al. Swimming exercise ameliorates depression-like behavior in chronically stressed rats: relevant to pro-inflammatory cytokines and IDO activation. Behav Brain Res. 2013;242:110–116.
26. Liu XL, Luo L, Liu BB, et al. Ethanol extracts from Hemerocallis citrina attenuate the upregulation of pro-inflammatory cytokines and indoleamine 2,3-dioxygenase in rats. J Ethnopharmacol. 2014;153:484–490.
27. Mutlu O, Gumuslu E, Ulak G, et al. Effects of fluoxetine, tianeptine and olanzapine on unpredictable chronic mild stress-induced depression-like behavior in mice. Life Sci. 2012;91:1252–1262.
28. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res. 2005;161:45–59.
29. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. New York, NY, USA: Elsevier Academic Press; 1997.
30. Zhang Y, Xu H, Jiang W, et al. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse. Schizophr Res. 2008;106:182–191.
31. Xu H, Yang HJ, Zhang Y, Clough R, Browning R, Li XM. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. Behav Neurosci. 2009;123:418–429.
32. Yang HJ, Wang H, Zhang Y, et al. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: implications for the pathophysiology of schizophrenia. Brain Res. 2009;1270:121–130.
33. Xu H, Qing H, Lu W, et al. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett. 2002;321:65–68.
34. Mizoguchi K, Ishige A, Aburada M, Tabira T. Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience. 2003;119:887–897.
35. Elbejjani M, Fuhrer R, Abrahamowicz M, et al. Hippocampal atrophy and subsequent depressive symptoms in older men and women: results from a 10-year prospective cohort. Am J Epidemiol. 2014;180:385–393.
36. Tanebe K, Nishijo H, Muraguchi A, Ono T. Effects of chronic stress on hypothalamic interleukin-1beta, interleukin-2, and gonadotrophin-releasing hormone gene expression in ovariectomized rats. J Neuroendocrinol. 2000;12:13–21.
37. Kumar B, Kuhad A, Chopra K. Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences. Psychopharmacology (Berl). 2011;214:819–828.
38. Schaalan MF, Nassar NN. Effects of octreotide in chronically mild stressed rats: possible role of immune and oxidative stress pathways. Neurochem Res. 2011;36:1717–1723.
39. Jindal A, Mahesh R, Bhatt S. Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: modulation of hypothalamic-pituitary-adrenal axis activity and brain-derived neurotrophic factor level. Neurochem Int. 2013;63:465–475.
40. Nguyen KT, Deak T, Owens SM, et al. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci. 1998;18:2239–2246.
41. Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav. 2005;84:697–706.
42. You Z, Luo C, Zhang W, et al. Pro- and anti-inflammatory cytokines expression in rat’s brain and spleen exposed to chronic mild stress: involvement in depression. Behav Brain Res. 2011;225:135–141.
43. Flora G, Lee YW, Nath A, Maragos W, Hennig B, Toborek M. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. Neuromolecular Med. 2002;2:71–85.
44. Ferri CC, Ferguson AV. Interleukin-1 beta depolarizes paraventricular nucleus parvocellular neurones. J Neuroendocrinol. 2003;15:126–133.
45. Gdek-Michalska A, Bugajski J. Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis. Pharmacol Rep. 2010;62:969–982.
46. Pasquini LA, Calatayud CA, Bertone U, et al. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res. 2007;32:279–292.
47. Yang HJ, Wang L, Cheng Q, Xu H. Abnormal behaviors and microstructural changes in white matter of juvenile mice repeatedly exposed to amphetamine. Schizophr Res Treatment. 2011;2011:542896.
48. French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB. Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res. 2009;87:3076–3087.
49. Xu H, Yang HJ, Li XM. Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone. Eur Arch Psychiatry Clin Neurosci. 2014;264:121–129.
50. Xuan Y, Yan G, Peng H, Wu R, Xu H. Concurrent changes in (1)H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: possible implications for schizophrenia. Neurochem Int. 2014;69:20–27.